Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study

BACKGROUND: Intravenous (IV) ketamine and intranasal (IN) esketamine have been studied as novel alternatives to manage treatment-resistant depression (TRD). The objective of this observational pilot study is to compare the real-world effectiveness and tolerability of IV ketamine and IN esketamine in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Gilmar, Rosenblat, Joshua, Hawken, Emily, Swainson, Jennifer, Vazquez, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171596/
https://www.ncbi.nlm.nih.gov/pubmed/35604752
http://dx.doi.org/10.2196/34711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171596/
https://www.ncbi.nlm.nih.gov/pubmed/35604752
http://dx.doi.org/10.2196/34711

Ejemplares similares